Literature DB >> 26872

Variable content of histaminase, L-dopa decarboxylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implications.

S B Baylin, W R Weisburger, J C Eggleston, G Mendelsohn, M A Beaven, M D Abeloff, D S Ettinger.   

Abstract

To ascertain whether the content of endocrine markers is constant in small-cell carcinoma of the lung, levels of three markers of medullary thyroid carcinoma were studied in this tumor. Histaminase was increased in six of six primary tumors (three to 14,000 times), L-dopa decarboxylase in four of six (six to 30 times), and calcitonin in one of one (eight times) over levels in adjacent lung. Marker levels in mediastinal metastases reflected those in primary tumors in four of five patients. However, in four of seven, multiple hepatic metastases contained low to absent levels despite simultaneously high values in chest lesions. Immunohistochemical studies of histaminase revealed that within each primary tumor different cells contained different amounts of the enzyme. Since marker content varied between tumor cells, between primary tumors and between metastases in individual patients we conclude that circulating levels of these three markers cannot be expected necessarily to mirror tumor burden in patients with small-cell lung tumors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 26872     DOI: 10.1056/NEJM197807202990301

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  28 in total

1.  L-Dopa decarboxylase expression profile in human cancer cells.

Authors:  Ioanna Chalatsa; Eleftheria Nikolouzou; Emmanuel G Fragoulis; Dido Vassilacopoulou
Journal:  Mol Biol Rep       Date:  2010-06-11       Impact factor: 2.316

2.  Purification of an endogenous inhibitor of L-Dopa decarboxylase activity from human serum.

Authors:  Alice-Georgia Vassiliou; Dido Vassilacopoulou; Emmanuel G Fragoulis
Journal:  Neurochem Res       Date:  2005-05       Impact factor: 3.996

3.  Release of membrane-associated L-dopa decarboxylase from human cells.

Authors:  Ioanna Chalatsa; Emmanuel G Fragoulis; Dido Vassilacopoulou
Journal:  Neurochem Res       Date:  2011-04-11       Impact factor: 3.996

Review 4.  Review: biologic heterogeneity of cancer metastases.

Authors:  I J Fidler
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

5.  Tumor heterogeneity: biological implications and therapeutic consequences.

Authors:  G H Heppner; B E Miller
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

6.  Age-associated C-cell hyperplasia in the human thyroid.

Authors:  W G Gibson; T C Peng; B P Croker
Journal:  Am J Pathol       Date:  1982-03       Impact factor: 4.307

7.  Histamine content, diamine oxidase activity and histamine methyltransferase activity in human tissues: fact or fictions?

Authors:  R Hesterberg; J Sattler; W Lorenz; C D Stahlknecht; H Barth; M Crombach; D Weber
Journal:  Agents Actions       Date:  1984-04

Review 8.  Generation of phenotypic diversity and progression in metastatic tumor cells.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

9.  Expression of a neural type of intermediate filament as a distinguishing feature between oat cell carcinoma and other lung cancers.

Authors:  V P Lehto; S Stenman; M Miettinen; D Dahl; I Virtanen
Journal:  Am J Pathol       Date:  1983-02       Impact factor: 4.307

10.  The selective nature of metastasis.

Authors:  J E Talmadge
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.